VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Upcoming agents in ET and PV

Ruben Mesa, MD, UT Health San Antonio MD Anderson Cancer Center, San Antonio, TX, gives an overview of upcoming agents in polycythemia vera (PV) and essential thrombocythemia (ET), including ropeginterferon alfa-2b, bomedemstat, and rusfertide, and clinical trials investigating these agents. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter